Company / EPS (Basic)
MAXCYTE, INC. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.39
FY2025
5-year range
-$0.39 / -$0.21
FY2021-FY2025
Trend
-5.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has declined for 3 consecutive years, from $-0.21 in FY2022 to $-0.39 in FY2025.
Based on SEC 10-K filings.
-0.39 in FY2025.
Declined from $-0.23 to $-0.39 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- MAXCYTE, INC.'s eps (basic) has declined for 3 consecutive years.
- In FY2025, eps (basic) decreased 5.4% year-over-year.
- Peak eps (basic) was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.39 | -5.4% |
| FY2024 | -$0.37 | -60.9% |
| FY2023 | -$0.23 | -9.5% |
| FY2022 | -$0.21 | +8.7% |
| FY2021 | -$0.23 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026